3Vote!
Forex Analytics (Free subscription) | 11/22/2009
Pharmaceutical company AstraZeneca plc (AZN, AZN.L) said Thursday it has submitted has New Drug Application for ticagrelor to the U.S. Food and Drug Administration. Ticagrelor is oral year investigational antiplatelet treatment to reduce unfavourable major cardiac vents in patients with acute coronary syndrome. The proposed trade name for ticagrelor is Brilinta, which is yet to [...] Post from: (c)Autor:...
5Vote!
PharmaGossip (Free subscription) | 11/21/2009
Companies: Astrazeneca Plc BOSTON, Nov. 20 /PRNewswire/ -- The United States Court of Appeals for the First Circuit upheld an earlier District Court ruling yesterday, approving a settlement in the long-running Average Wholesale Price (AWP) pharmaceutical litigation against AstraZeneca Pharmaceuticals (NYSE: AZN - News ). (Logo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM144LOGO ) The ruling affirms...
3Vote!
The Legal Reader (Free subscription) | 11/20/2009
If so, I foresee a lot of money being spent by both sides to retain local counsel… Nov. 19 (Bloomberg) -- AstraZeneca Plc may face as many 6,000 trials of lawsuits claiming its antipsychotic drug Seroquel causes diabetes after a...
6Vote!
PharmaGossip (Free subscription) | 11/19/2009
Nov. 19 (Bloomberg) -- AstraZeneca Plc may face as many 6,000 trials of lawsuits claiming its antipsychotic drug Seroquel causes diabetes after a judge said she will recommend sending the cases back to their home courts. U.S. District Judge Anne Conway in Orlando, Florida, who is overseeing pre-trial proceedings in federal Seroquel litigation, said yesterday she’ll urge a panel of judges to...
3Vote!
Canadian Online Health News (Free subscription) | 11/19/2009
LONDON - AstraZeneca PLC said Thursday it has applied to U.S. regulators to market its blood clot preventer Brilinta, a potential new big seller for the company. AstraZeneca submitted a new drug application to the U.S.
4Vote!
Market Watch (Free subscription) | 11/17/2009
BOSTON (MarketWatch) -- The Food and Drug Administration warned Tuesday that taking the blood-thinner Plavix with the antacid Prilosec can reduce Plavix's effectiveness by as much as half. Plavix, the world's second best-selling drug, is co-marketed by Sanofi-Aventis and Bristol-Myers Squibb . Prilosec, also known as omeprazole, belongs to a group of widely-used antacids called PPIs. The agency also...
3Vote!
Sify (Free subscription) | 11/13/2009
Eli Lilly&Co. said Friday its science and technology head will retire. The drugmaker hired the chief researcher at AstraZeneca PLC to replace him.
4Vote!
Miami Herald (Free subscription) | 11/13/2009
Eli Lilly & Co. said Friday its science and technology head will retire and that it has hired the chief researcher at AstraZeneca PLC to replace him.
4Vote!
Miami Herald (Free subscription) | 11/13/2009
Eli Lilly & Co. said Friday its science and technology head will retire and that it has hired the chief researcher at AstraZeneca PLC to replace him.
5Vote!
San Fransisco Chronicle (Free subscription) | 11/13/2009
Eli Lilly & Co. said Friday its science and technology head will retire and that it has hired the chief researcher at AstraZeneca PLC to replace him. The drugmaker, which is based in Indianapolis, said Steven Paul will retire on Feb. 28, 2010. Paul, 59, is in... Indianapolis - Eli Lilly and Company - Eli Lilly - Eli Lilly & Co - Patent
7Vote!
Seattle Times (Free subscription) | 11/13/2009
Eli Lilly & Co. said Friday its science and technology head will retire and that it has hired the chief researcher at AstraZeneca PLC to replace him.
9Vote!
PharmaGossip (Free subscription) | 11/12/2009
[The second part of this story is at: Astrazeneca and Wikipedia: More Edits Uncovered ] I’ve been playing with an interesting new tool called Wikiscanner, intended to “list anonymous wikipedia edits from interesting organisations”. I’ve been looking at what kind of information various pharmaceutical companies put into Wikipedia anonymously. After all, Wikipedia has become a...
5Vote!
Drug and Device Law (Free subscription) | 11/09/2009
No, we're not talking about the McClellan Kerr Project that turned Little Rock and Tulsa, of all places, into seaports. We're talking consumer protection lawsuits against pharmaceutical companies (aren't we always). We've mentioned a couple of times before that a lot of consumer protection laws contain "safe harbor" provisions that bar suits over conduct that was "authorized"/"approved"/"permitted"...
5Vote!
43(B)log (Free subscription) | 11/07/2009
DePriest v. AstraZeneca Pharmaceuticals, L.P., --- S.W.3d ----, 2009 Ark. 547, 2009 WL 3681868 (Ark.) Plaintiffs sued AstraZeneca for false advertising of Nexium. Prilosec, Nexium’s predecessor, aka “The Purple Pill,” was AZ’s most profitable drug when its patent expired in 2001. In 2001, the FDA approved AZ’s request to market Nexium to treat conditions relating to gastro-esophageal...
5Vote!
Philadelphia Inquirer (Free subscription) | 10/30/2009
Drugmaker AstraZeneca P.L.C. said yesterday that it had set aside $520 million as part of a tentative agreement to resolve an investigation by federal prosecutors in Philadelphia into the company's marketing practices.
4Vote!
aarkstore | 09/11/2009
AstraZeneca PLC - Financial and Strategic Analysis Review Summary : AstraZeneca PLC (AstraZeneca) is a leading pharmaceuticals company engaged in the design, development, production and marketing of a broad range of prescription pharmaceuticals, biologics and vaccines to fight disease in the areas of healthcare; such as cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory...
Videos